Last Updated:
Access Report
Name Designation Appointment Date Status
Suresh Adapa

Appointed as Additional Director since August 2015

 Additional Director 25-Aug-2015 Current
Name Designation Appointment Date Status
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Tamma Sandhya Rani

Appointed as Additional Director since July 2016

 Additional Director 01-Jul-2016 Current

People Timeline

Explore the timeline of key personnel in Newfin Pharmaceuticals Private Limited's leadership journey.

Contact Details
  • Address 6-3, Sterling Emerald,Plot No.118, Bhagyanagar Colony,, Kukatpally, Hyderabad Telangana, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code
  • Country India
  • Website -
  • Social Media
Frequently Asked Questions
How can I contact Newfin Pharmaceuticals Private Limited?
You can contact Newfin Pharmaceuticals Private Limited through their registered address at 6-3, Sterling Emerald,Plot No.118, Bhagyanagar Colony,, Kukatpally, Hyderabad Telangana, India, or via their website if available. Social media links are also provided where applicable.
Who are the current directors of Newfin Pharmaceuticals Private Limited?
The current directors of Newfin Pharmaceuticals Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • SURESH ADAPA
  • TAMMA SANDHYA RANI
How can I access past director details?
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available